Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma
Authors:
- 1 August 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 212 (2) , 331-341
Abstract
The AUA guidelines introduced a new risk group stratification system based primarily on tumor stage and grade to guide surveillance for patients treated surgically for localized renal cell carcinoma (RCC). We sought to evaluate the predictive ability of these risk groups using progression-free survival (PFS) and cancer-specific survival (CSS), and to compare their performance to that of our published institutional risk models. We queried our Nephrectomy Registry to identify adults treated with radical or partial nephrectomy for unilateral, M0, clear cell RCC, or papillary RCC from 1980 to 2012. The AUA stratification does not apply to other RCC subtypes as tumor grading for other RCC, such as chromophobe, is not routinely performed. PFS and CSS were estimated using the Kaplan-Meier method. Predictive abilities were evaluated using C indexes from Cox proportional hazards regression models. A total of 3191 patients with clear cell RCC and 633 patients with papillary RCC were included. For patients with clear cell RCC, C indexes for the AUA risk groups and our model were 0.780 and 0.815, respectively (P < .001) for PFS, and 0.811 and 0.857, respectively (P < .001), for CSS. For patients with papillary RCC, C indexes for the AUA risk groups and our model were 0.775 and 0.751, respectively (P = .002) for PFS, and 0.830 and 0.803, respectively (P = .2) for CSS. The AUA stratification is a parsimonious system for categorizing RCC that provides C indexes of about 0.80 for PFS and CSS following surgery for localized clear cell and papillary RCC.Keywords
This publication has 22 references indexed in Scilit:
- Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell CarcinomaNew England Journal of Medicine, 2021
- Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor NecrosisEuropean Urology, 2021
- Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient SurvivalClinical Genitourinary Cancer, 2019
- Predicting Oncologic Outcomes in Renal Cell Carcinoma After SurgeryEuropean Urology, 2018
- Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical NephrectomyJournal of Urology, 2015
- Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell CarcinomaEuropean Urology, 2015
- Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carcinoma: Results From a Large, Single Institution CohortJournal of Urology, 2011
- Renal cell carcinomaThe Lancet, 2009
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinomaCancer, 2003
- An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign ScoreJournal of Urology, 2002